NCT04067336 2026-05-13First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid LeukemiaKura Oncology, Inc.Phase 1/2 Active not recruiting263 enrolled 1 FDA
NCT03043430 2023-04-25Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department PatientsBrooke Army Medical CenterPhase 4 Terminated10 enrolled